The Company Enveric Biosciences Inc. (United States), is listed on Nasdaq with a market value of $ 12.69 Millions, having an equity of $ 3.46 Millions.
With a total of 3 employees, the company is listed in the sector of Health and categorized in industry of Pharmaceutical Products.
In the last 12 months the Company had a revenue of $ -, which generated a loss in the amount of $ -9.72 Millions.
As for its main indicators, the Company has a P/E ratio of -1.31, a P/BV ratio of 3.67 and in the last 12 months the Company did not pay dividends.
The Company is traded internationally through the ticker ENVB.